Menu
Medical instrument manufacturer ZimVie (ZIMV) Thursday said it has furthered cooperation with diversified spine imaging firm Brainlab and started a project to make their systems…
ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie''s Vital and Virage® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes W…
ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage ® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes
ZimVie (ZIMV) traded higher pre-market Thursday after announcing that the FDA approved a smaller height of its Mobi-C cervical disc implant. Read more here.
https://www.investing.com/news/assorted/zimvie-inc-announces-fda-approval-for-new-mobic-implant-432SI-3151207
Smaller height implants in all Mobi-C footprints to address patient anatomy WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1st, 2023, the U.S. Food and Drug Administration approved a smaller height of the Mobi-C Cervical Disc in seven footprints that will address the
The following slide deck was published by ZimVie Inc.
https://www.investing.com/news/pro/zimvie-receives-investment-bank-analyst-rating-update-3147597
